SFRP5 and type 2 diabetes mellitus: In the second data, it emerged that in the human population with type 2 diabetes mellitus, the serum concentration of SFRP5 was strongly consistent with the brachial-ankle pulse wave velocity (r = 0.146; p = 0.024).